A detailed history of Paradigm Asset Management CO LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Paradigm Asset Management CO LLC holds 12,200 shares of ABBV stock, worth $2.14 Million. This represents 0.91% of its overall portfolio holdings.

Number of Shares
12,200
Previous 12,200 -0.0%
Holding current value
$2.14 Million
Previous $2.09 Million 15.15%
% of portfolio
0.91%
Previous 0.84%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $1.51 Million - $1.76 Million
-9,750 Reduced 44.42%
12,200 $2.09 Million
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $87,901 - $100,155
-550 Reduced 2.44%
21,950 $4 Million
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $82,560 - $92,982
-600 Reduced 2.6%
22,500 $3.49 Million
Q3 2023

Oct 31, 2023

SELL
$133.59 - $154.65 $173,667 - $201,045
-1,300 Reduced 5.33%
23,100 $3.44 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $1.05 Million - $1.3 Million
7,900 Added 47.88%
24,400 $3.29 Million
Q4 2022

Feb 13, 2023

BUY
$138.31 - $165.87 $1.7 Million - $2.04 Million
12,300 Added 292.86%
16,500 $2.67 Million
Q3 2022

Nov 09, 2022

SELL
$134.21 - $153.93 $93,947 - $107,751
-700 Reduced 14.29%
4,200 $564 Million
Q2 2022

Aug 08, 2022

BUY
$137.62 - $174.96 $674,338 - $857,304
4,900 New
4,900 $750,000
Q4 2020

Feb 12, 2021

SELL
$80.49 - $108.67 $672,091 - $907,394
-8,350 Closed
0 $0
Q2 2020

Aug 11, 2020

BUY
$73.37 - $98.18 $506,253 - $677,442
6,900 Added 475.86%
8,350 $819,000
Q4 2019

Feb 12, 2020

BUY
$72.13 - $90.25 $14,426 - $18,050
200 Added 16.0%
1,450 $128,000
Q2 2019

Aug 08, 2019

SELL
$65.7 - $83.98 $522,315 - $667,641
-7,950 Reduced 86.41%
1,250 $0
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $61,712 - $72,632
-800 Reduced 8.0%
9,200 $0
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $70,065 - $86,409
-900 Reduced 8.26%
10,000 $921,000
Q3 2018

Nov 19, 2018

SELL
$88.91 - $98.84 $1.05 Million - $1.17 Million
-11,800 Reduced 51.98%
10,900 $0
Q1 2018

May 07, 2018

SELL
$92.01 - $123.21 $110,412 - $147,852
-1,200 Reduced 5.02%
22,700 $0
Q4 2017

Feb 12, 2018

BUY
$89.56 - $98.21 $2.14 Million - $2.35 Million
23,900
23,900 $0

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Paradigm Asset Management CO LLC Portfolio

Follow Paradigm Asset Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Asset Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Asset Management CO LLC with notifications on news.